BioCentury
ARTICLE | Clinical News

Vitae preclinical data

September 17, 2012 7:00 AM UTC

In primates, VTP-4 increased biomarkers of reverse cholesterol transport (RCT) at doses >=30 times lower than doses that cause triglyceride elevations in the plasma or liver, according to Vitae. The c...